Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapy (Q72678559)
Jump to navigation
Jump to search
scientific article published on 01 June 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapy |
scientific article published on 01 June 1994 |
Statements
Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapy (English)
A Schomburg
H Kirchner
E Lopez-Hänninen
T Menzel
P Rudolph
A Körfer
M Fenner
H Poliwoda